Dr. Reddy's
RDY
$71.31
Share price
-0.42%
Change (1 day)
18.95%
Change (1 year)
Categories
Operating Margin for Dr. Reddy's (RDY)
Operating Margin as of April 2024 (TTM): 24.69%
According to Dr. Reddy's's latest financial reports and stock price the company's current Operating Margin is 24.69%. At the end of 2023 the company had an Operating Margin of 24.60%.
Operating Margin history for Dr. Reddy's from 2002 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | 24.60% | 63.29% |
| 2022 | 15.06% | 0.91% |
| 2021 | 14.93% | 44.56% |
| 2020 | 10.33% | -29.2% |
| 2019 | 14.59% | 44.47% |
| 2018 | 10.10% | -2.97% |
| 2017 | 10.41% | -40.68% |
| 2016 | 17.54% | -7.69% |
| 2015 | 19.00% | -5.59% |
| 2014 | 20.13% | 7.97% |
| 2013 | 18.64% | -2.33% |
| 2012 | 19.09% | 14.59% |
| 2011 | 16.66% | 470.26% |
| 2010 | 2.92% | -150.77% |
| 2009 | -5.75% | -183.7% |
| 2008 | 6.88% | -57.38% |
| 2007 | 16.13% | 107.41% |
| 2006 | 7.78% | 1314.92% |
| 2005 | 0.55% | -95.65% |
| 2004 | 12.65% | -41.85% |
| 2003 | 21.75% | -28.75% |
| 2002 | 30.53% | 215.09% |
| 2001 | 9.69% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 17.27% | -30.05% | 🇨🇭 Switzerland |
 Pfizer PFE | 34.61% | 40.18% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -26.25% | 🇫🇷 France |
 GlaxoSmithKline GSK | 22.54% | -8.71% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -20.53% | -183.15% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.